Dirk Foell Selected Research

S100A12 Protein

1/2022	Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial.
1/2021	Impact of chorioamnionitis on maternal and fetal levels of proinflammatory S100A12.
8/2020	Evaluation of the S100 protein A12 as a biomarker of neonatal sepsis.
1/2019	Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
1/2019	Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
1/2019	Effect of Adalimumab on Peripheral Blood Mononuclear Cells in Non-Infectious Uveitis.
10/2018	Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
1/2018	S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies.
1/2018	S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.
5/2016	Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Foell Research Topics

Disease

53	Inflammation (Inflammations) 11/2022 - 04/2003
39	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2022 - 09/2003
16	Arthritis (Polyarthritis) 05/2021 - 04/2004
8	Infections 04/2022 - 07/2007
8	Crohn Disease (Crohn's Disease) 01/2021 - 10/2005
8	Vasculitis (Vasculitides) 01/2021 - 09/2004
8	Fever (Fevers) 01/2020 - 06/2009
7	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 05/2022 - 04/2003
7	Cryopyrin-Associated Periodic Syndromes 01/2022 - 12/2008
7	Neoplasms (Cancer) 01/2022 - 10/2008
6	Rheumatoid Arthritis 01/2021 - 01/2005
6	Uveitis 01/2019 - 12/2015
5	Sepsis (Septicemia) 01/2020 - 09/2007
5	Familial Mediterranean Fever (Periodic Disease) 01/2017 - 04/2010
4	Necrosis 01/2022 - 06/2012
4	Macrophage Activation Syndrome 11/2021 - 01/2016
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 05/2013
4	Colitis 07/2015 - 10/2005
3	Ulcerative Colitis 01/2021 - 07/2020
3	Pharyngitis (Sore Throat) 01/2020 - 01/2011
3	Exanthema (Rash) 01/2020 - 04/2005
3	Autoimmune Diseases (Autoimmune Disease) 01/2011 - 09/2003
3	Shock 12/2009 - 09/2007
2	COVID-19 05/2022 - 10/2021
2	Disease Progression 04/2022 - 01/2017
2	Mevalonate Kinase Deficiency 01/2022 - 01/2022
2	Adult-Onset Still's Disease 09/2021 - 01/2020
2	Pre-Eclampsia (Preeclampsia) 08/2020 - 02/2015
2	Systemic Vasculitis 01/2018 - 04/2005
2	Gout 07/2017 - 05/2014
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 01/2014
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2014 - 02/2009
2	Aphthous Stomatitis (Aphthous Ulcer) 11/2013 - 01/2011
2	Necrotizing Enterocolitis 08/2013 - 12/2012
2	Fever of Unknown Origin 06/2012 - 12/2008
1	COVID-19 related pediatric multisystem inflammatory disease 05/2022
1	Thymoma (Thymic Carcinoma) 04/2022
1	Myasthenia Gravis 04/2022

Drug/Important Bio-Agent (IBA)

31	S100A12 ProteinIBA 01/2022 - 04/2003
27	Biomarkers (Surrogate Marker)IBA 11/2022 - 06/2004
27	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2003
11	Interleukin-1 (Interleukin 1)IBA 01/2022 - 03/2011
11	S100 Proteins (S 100 Protein)IBA 08/2020 - 06/2004
10	CytokinesIBA 09/2021 - 06/2009
7	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2022 - 10/2016
7	C-Reactive ProteinIBA 01/2022 - 02/2009
7	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2016 - 04/2004
7	LigandsIBA 05/2014 - 12/2007
5	Methotrexate (Mexate)FDA LinkGeneric 09/2022 - 04/2010
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2022 - 03/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2005
5	AlarminsIBA 07/2017 - 09/2009
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 05/2011
5	Toll-Like Receptor 4IBA 05/2014 - 09/2007
5	Receptor for Advanced Glycation End ProductsIBA 05/2011 - 04/2003
4	AutoantibodiesIBA 05/2022 - 05/2011
4	AntibodiesIBA 05/2022 - 12/2013
4	canakinumab FDA Link 11/2021 - 12/2011
4	Interleukin-18 (Interleukin 18)IBA 10/2021 - 01/2018
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2019 - 01/2014
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 08/2007
4	Polysaccharides (Glycans)IBA 09/2012 - 10/2005
3	InterleukinsIBA 01/2022 - 12/2011
3	tofacitinibIBA 01/2021 - 07/2020
3	Janus KinasesIBA 01/2021 - 07/2020
3	Interleukin-17 (Interleukin 17)IBA 01/2021 - 06/2010
3	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2011
3	Antinuclear AntibodiesIBA 07/2020 - 09/2012
3	Adalimumab (Humira)FDA Link 01/2019 - 10/2018
3	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2015 - 07/2007
3	EnzymesIBA 05/2014 - 12/2007
3	ImmunosorbentsIBA 05/2014 - 12/2007
3	NF-kappa B (NF-kB)IBA 10/2008 - 10/2005
2	amsonic acid (DAS)IBA 11/2022 - 03/2011
2	Immunoglobulin G (IgG)IBA 02/2022 - 09/2012
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 09/2004
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
2	GlucocorticoidsIBA 01/2020 - 01/2018
2	A-factor (Streptomyces)IBA 01/2019 - 05/2011
2	Interleukin-6 (Interleukin 6)IBA 04/2018 - 10/2008
2	sulfated polyvinyl alcoholIBA 01/2018 - 01/2017
2	Uric Acid (Urate)IBA 07/2017 - 05/2014
2	Colchicine FDA LinkGeneric 01/2017 - 04/2010
2	PyrinIBA 12/2016 - 11/2015
2	Calcium-Binding ProteinsIBA 05/2016 - 04/2003
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2016 - 05/2011
2	Dextrans (Dextran)FDA Link 01/2016 - 05/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2015 - 11/2013
2	Biological ProductsIBA 03/2015 - 01/2005
2	rilonacept FDA Link 09/2013 - 12/2011
2	EndotoxinsIBA 09/2009 - 09/2007
2	CalciumIBA 04/2009 - 06/2004
2	Glycoproteins (Glycoprotein)IBA 10/2008 - 10/2005
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 11/2022
1	ProgranulinsIBA 05/2022

Therapy/Procedure

16	Therapeutics 01/2022 - 01/2007
2	Biological Therapy 01/2020 - 03/2015
2	Intravenous Injections 01/2016 - 12/2009
1	Artificial Respiration (Mechanical Ventilation) 04/2022